ATLANTA — A federal advisory panel that recommends vaccines for the public voted Friday to restrict access to the combined measles, mumps, rubella, and varicella (MMRV) shot for low-income children under the age of 4. This decision reflects growing concerns regarding the safety profile of the combined vaccine, particularly the associated risk of seizures following administration.
Children in this demographic will still have the option to receive separate MMR and varicella vaccinations, which the Centers for Disease Control and Prevention (CDC) has indicated as the preferred approach due to the lower risk of adverse effects. This shift in policy may have significant implications for public health strategies aimed at increasing vaccination rates among vulnerable populations, potentially complicating access to immunization for those who rely on combined vaccines for convenience and cost-effectiveness.
Use the database as your supply chain compass →
